3 April 2025

Last updated: Sunday 30 March 2025

Gene therapy

Purespring to develop gene therapies for the kidney

Integrated product development for ATMPs

A new paradigm for cancer therapy emerges

The role of base and prime editing in therapeutics

Gene-edited therapies produce first clinical data

Gene and cell therapy as a new pillar of medicine

COVID-19's logistical impact on advanced therapies

Solving the viral vector bottleneck during a pandemic

The changing landscape for haemophilia treatment

Meeting the challenge of viral vector manufacture